Category: Palliative Care

EP136-2 - Primary Thromboprophylaxis in Non-cancer Patients Admitted to a Geriatric Palliative Care Unit

Thursday, Nov 23
4:20 PM – 4:35 PM

Background
Patients with end-stage, noncancer disease are increasing in prevalence on Palliative Care Units. The aim of this study is to compare venous thromboembolism (VTE) prophylaxis in elderly patients with noncancer diagnoses to those with advanced cancer on a dedicated Palliative Care Unit.

Methods
This was a single-centre retrospective chart review for all patients admitted to and discharged from the Baycrest Health Sciences Palliative Care Unit in 2016. We measured the association between demographic data and palliative performance scale, admission source and length of stay in patients with cancer and noncancer diagnoses.

Results
316 patients were included in the final analysis, 18% of whom had a noncancer diagnosis. VTE Prophylaxis was administered in 32% of the cancer patients and 27% of the noncancer patients (p=0.285). 67% of the patients were admitted from hospital while 30% were admitted from home. Patients admitted from hospital were more likely to receive VTE prophylaxis ( p < 0.05). Mean admission PPS score was 31 for noncancer and 36 for cancer patients (p < 0.05). Length of stay was shorter for patients with a PPS < 30 (p < 0.05).

Conclusion
This study shows that VTE prophylaxis rates were similar between cancer and noncancer patients on a geriatric Palliative Care Unit. There are no current guidelines to direct VTE prophylaxis decisions in noncancer Palliative Care Unit inpatients, but further research would help to better guide these decisions and minimize suffering for patients at the end of life.

Giulia-Anna Perri

Medical Director, Palliative and End-of-Life Care, Baycrest Health Sciences
Division of Palliative Care, Department of Family and Community Medicine, U of T, Ontario, Canada

Dr. Giulia-Anna Perri is the Medical Director for Palliative and End-of-Life Care at Baycrest Health Sciences. She is an Assistant Professor within the Division of Palliative Care, Department of Family and Community Medicine at the University of Toronto.

Giulia-Anna Perri

Medical Director, Palliative and End-of-Life Care, Baycrest Health Sciences
Division of Palliative Care, Department of Family and Community Medicine, U of T, Ontario, Canada

Dr. Giulia-Anna Perri is the Medical Director for Palliative and End-of-Life Care at Baycrest Health Sciences. She is an Assistant Professor within the Division of Palliative Care, Department of Family and Community Medicine at the University of Toronto.

Giulia-Anna Perri

Medical Director, Palliative and End-of-Life Care, Baycrest Health Sciences
Division of Palliative Care, Department of Family and Community Medicine, U of T, Ontario, Canada

Dr. Giulia-Anna Perri is the Medical Director for Palliative and End-of-Life Care at Baycrest Health Sciences. She is an Assistant Professor within the Division of Palliative Care, Department of Family and Community Medicine at the University of Toronto.